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The formation of macromolecular complexes within
the crowded environment of cells often requires aid
from assembly chaperones. PRMT5 and SMN com-
plexesmediate this task for the assembly of the com-
mon core of pre-mRNA processing small nuclear
ribonucleoprotein particles (snRNPs). Core forma-
tion is initiated by the PRMT5-complex subunit pICln,
which pre-arranges the core proteins into spatial
positions occupied in the assembled snRNP. The
SMN complex then accepts these pICln-bound
proteins and unites them with small nuclear RNA
(snRNA). Here, we have analyzed how newly synthe-
sized snRNP proteins are channeled into the assem-
bly pathway to evade mis-assembly. We show that
they initially remain bound to the ribosome near the
polypeptide exit tunnel and dissociate upon associa-
tion with pICln. Coincident with its release activity,
pICln ensures the formation of cognate heteroo-
ligomers and their chaperoned guidance into the as-
sembly pathway. Our study identifies the ribosomal
quality control hub as a site where chaperone-medi-
ated assembly of macromolecular complexes can be
initiated.INTRODUCTION
Recent systematic interaction profiling of the proteome revealed
a strong modularity, where most proteins and/or nucleic acids
are incorporated into complexes (Gavin et al., 2006). These com-
plexes, on average, contain ten subunits and are composed
of proteins alone or proteins and nucleic acids (Gavin et al.,
2006). Hence, macromolecular assemblies perform the vast ma-
jority of cellular activities. The faithful assembly of these com-
plexes is, therefore, a vital challenge of all cells, and its failure
often has profound consequences. The assembly process is
often complicated by the fact thatmany newly synthesized build-
ing blocks only attain their folded structure within the context of
their respective complex. As a consequence, single subunitsCell Report
This is an open access article undhave the tendency tomisfold, aggregate, or engage in erroneous
interactions within the crowded environment of cells. Therefore,
the formation of macromolecular complexes in vivo, in many
cases, depends on trans-acting factors, which sequester individ-
ual subunits and safeguard them until incorporated into higher
order assemblies (Chari and Fischer, 2010). Indeed, in some
cases, the number of trans-acting assembly factors exceeds
the number of parts to be assembled, as exemplified for the
common Sm/Lsm core structure of the pre-mRNA processing
small nuclear ribonucleoprotein particles (snRNPs) (Fischer
et al., 2011).
Two classes of snRNPs mediate defined pre-mRNA process-
ing reactions in eukaryotes. The first comprises the spliceosomal
snRNPs involved in pre-mRNA splicing. They are characterized
by a set of seven ‘‘Sm’’ proteins that forms their common struc-
tural core. These proteins, termed SmB/B’, SmD1, SmD2,
SmD3, SmE, SmF, and SmG, encircle a single stranded region
of the snRNA (Sm site), to form the Sm core domain. Sm proteins
share the Sm-fold, consisting of an N-terminal a-helix followed
by a five-stranded antiparallel b sheet. In the assembled Sm
core, the b4 strand of one Sm protein connects to a b5 strand
of an adjacent Sm protein. This results in the formation of
a continuous, intermolecular b sheet among Sm proteins
SmE-SmG-SmD3-SmB-SmD1-SmD2-SmF that encloses the
Sm site (Kambach et al., 1999). The second class comprises
the histone 30-end processing U7 snRNP, which contains a
structurally similar core domain in which the classical Sm pro-
teins SmD1 and SmD2 are replaced by structurally related
‘‘like Sm’’ (Lsm) proteins Lsm10 and Lsm11 (Pillai et al., 2003).
Twelve trans-acting factors, united in PRMT5 and SMN com-
plexes, have been linked to snRNPs assembly in vivo. In the early
phase, the assembly chaperone pICln binds Smproteins and de-
livers them onto the PRMT5 complex (Chari et al., 2008). The
assembly pathway then segregates into two lines. In one line,
pICln forms a small nuclear RNA (snRNA)-free pseudo-Sm
core (termed 6S complex) together with Sm D1, D2, F, E and
G, where pICln occupies the position of the remaining two, Sm
B/B’ and D3. The other line consists of pICln-D3/B, which, unlike
6S, may not dissociate from the PRMT5 complex. In the late
phase of snRNP formation, the SMN complex dissociates pICln
from Sm proteins and enables their subsequent joining with
snRNA (Chari et al., 2008). Formation of the Sm/Lsm core of
the U7 snRNP particle appears to follow mechanistically similars 16, 3103–3112, September 20, 2016 ª 2016 The Author(s). 3103
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routes (Pillai et al., 2003). In this report, we have addressed the
conceptually unresolved question of how newly synthesized
Sm/Lsm proteins engage with cellular assembly machineries to
evade aggregation and/or mis-assembly. Unexpectedly, we un-
covered a role thus far unknown for the ribosome as a quality
control hub and a starting point for the chaperone-mediated as-
sembly process. While shown here specifically for snRNPs,
these principles may also find use in the assembly of other
macromolecular complexes.
RESULTS
Co-sedimentation of Lsm10 and Lsm11 with Polysomes
At steady state, the majority of Sm/Lsm proteins are either asso-
ciated with the assembly machinery or with snRNP particles
(Chari et al., 2008; Meister and Fischer, 2002). To investigate
earlier stages of assembly, we generated conditions where the
amounts of newly synthesized Sm/Lsm proteins exceeded
cellular levels of the essential assembly chaperone pICln. We
first focused on the assembly of the U7 snRNP core particle,
which consists of the Sm proteins B, D3, E, F, and G, as well
as the Lsm10/Lsm11 heterodimer. Tagged Lsm10 and Lsm11
proteins were expressed either alone or in combination by tran-
sient transfection, at levels that constitute approximately 20% of
the total amount of endogenous Lsm proteins (Figure S1A).
Therefore, throughout this article, the conclusions drawn by
the analysis of exogenous Lsm proteins are likely to reflect the
behavior of the endogenous proteins. Individually expressed
proteins localized to the cytoplasm as well as the nucleoplasm
(Figure S1B), as described for their endogenous counterparts
(Pillai et al., 2001, 2003). As intended, only a small fraction of
Lsm10/Lsm11 bound to pICln, as determined by immunoprecip-
itation (IP) (Figure S1C, lanes 1–8), suggesting that the assembly
chaperone pICln was limiting under these conditions. Size frac-
tionation of cellular extracts by gradient centrifugation revealed
that pICln sedimented as part of PRMT5 and 6S complexes, as
previously reported (Figure 1A, panel a) (Chari et al., 2008). Exog-
enous Lsm10 sedimented mostly as a free protein (Figure 1A,
panel b) and is bound only to substoichiometric amounts of
pICln, as shown by IP (Figure S1C, lanes 2, 6, 9, and 10). In
contrast, exogenous Lsm11 partially co-sedimented with the
PRMT5 complex but was predominantly present in a larger,
as-yet-uncharacterized species (Figure 1A, panel c). When
both cognate Lsm proteins were co-expressed, the majority of
Lsm10 shifted from the top of the gradient to fractions larger
than the PRMT5 complex (Figure 1A, panel d). In gradients
capable of resolving these heavy fractions, both exogenous
Lsm11 (Figure 1B, panel a) and co-expressed Lsm10/Lsm11
(Figure 1B, panel b) were found to co-sediment with ribosomes
and polysomes.
Association of Lsm10 and Lsm11 with the Large
Ribosomal Subunit
To provide evidence that Lsm10 and Lsm11 in these heavy frac-
tions represent ribosomal/polysomal-associated species, we
initially subjected the extract to a prolonged cycloheximide treat-
ment. This treatment led to the general shift of Lsm10/Lsm11
sedimentation from 80S fractions to polysomes (Figure S2A,3104 Cell Reports 16, 3103–3112, September 20, 2016panels a–c). However, when the extracts were incubated under
polysome runoff conditions, a shift of both Lsm proteins to
80S and smaller fractions was elicited (Figure S2A; compare
panel b with panel d). Lastly, puromycin treatment of the extract
caused Lsm proteins shift from polysomes to 80S fractions (Fig-
ure S2B; compare panels a and b). As these treatments selec-
tively modulate the sedimentation behavior of ribosomal species
and would not affect the behavior of random aggregates in any
manner, these and the following experiments fortify the notion
that Lsm11, alone or in complex with Lsm10, associates with
the translation machinery.
Next, we analyzed how this ribosomal interaction is estab-
lished and what significance this may have for snRNP assembly.
We found that Lsm11 and the co-expressed Lsm10/Lsm11
dimer stably bound to purified bulk ribosomes, albeit in a sub-
stoichiometric manner, as evident by their detection by western
blotting but the absence of a recognizable Lsm11 band in Coo-
massie-stained gels (Figure 1C, lanes 1–4).When ribosomes that
contained Lsm10 and Lsm11 were affinity selected from bulk
ribosomes with anti-hemagglutinin (HA) antibodies, a stoi-
chiometric complex of Lsm proteins with ribosomes became
apparent (Figure 1C, lane 7). The association of Lsm10/Lsm11
with ribosomes/polysomes withstood the treatment with up to
1M salt and is, therefore, unlikely to bemediated by non-specific
electrostatic interactions of the positively charged Lsm proteins
with rRNA (Figure 1D; compare lanes 7–13 with lanes 14–20).
Moreover, this association was mostly resistant to treatment
with 2% detergent (Figure 1D, lanes 21–26). Thus, under condi-
tions of pICln limitation, Lsm proteins associate with ribosomes
in a salt- and detergent-resistant manner. Notably, as polysome-
bound Lsm11 was detectable by its C-terminal FLAG tag (Fig-
ure S2C), this association is not a consequence of translational
pausing but reflects the full-length protein bound to ribosomes.
Importantly, the amount of full-length endogenous Lsm11
associated with ribosomes/polysomes was increased after the
reduction of cellular pICln levels by RNAi (Figure S2D).
To identify the region on the ribosome to which the Lsm pro-
teins bind, cellular extract (Figure 2A, upper panel) and purified
ribosomes/polysomes (Figure 2A, lower panel) were treated
with micrococcal nuclease (MNase) to digest mRNA. This treat-
ment was found to elicit the shift of Lsm10/Lsm11 from poly-
somes to 80S ribosomes. The consecutive treatment with
MNase and EDTA, which leads to the dissociation of 80S ribo-
somes, caused the co-sedimentation of Lsm10/Lsm11 with the
60S subunit (Figure 2B, panels a and b). To localize the binding
site of the Lsm proteins on the 60S subunit, we performed im-
muno-electron microscopy (EM) to detect the C-terminal FLAG
epitope in Lsm11. Purified MNase-treated 80S ribosomes con-
taining Lsm10/Lsm11 (as in Figure 2A) were incubated with
anti-FLAG antibodies at a ratio that led to the predominant
formation of two 80S ribosomes bridged by an antibody (Fig-
ure 2C, panel a). The region to which anti-FLAG antibodies
bound was analyzed on negatively stained electron micrographs
(Figure 2C, panels b–d). The antibodies detected full-length
Lsm11 on the ribosome in proximity of the polypeptide exit tun-
nel on the 60S subunit (Figure 2C), i.e., a prominent interaction
site for many chaperones, required for folding of nascent pro-
teins and their subsequent release into the cytoplasm.
Figure 1. Stable Association of Lsm10 and Lsm11 to Ribosomes
(A) Western blot analysis of cycloheximide-treated extracts fractionated by 10%–30% density gradients with anti-HA, anti-pICln, and anti-PRMT5 antibodies.
Cytoplasmic extracts were obtained from cells transfected with plasmids encoding for Lsm10 (b), Lsm11 (c) or both simultaneously (d). (a) depicts a repre-
sentative western blot of the endogenous PRMT5 and pICln proteins to reveal the sedimentation properties of 6S and PRMT5 complexes, respectively. See
also Figure S1C.
(B) 5%–40% high-resolution density gradient centrifugation to resolve high-molecular-weight complexes containing Lsm11 (a) or Lsm10/Lsm11 (b) visible in (A),
lanes 19–21. Fractions were analyzed by western blotting with antibodies against HA tag of Lsm10 and Lsm11 and ribosomal proteins L7 and S6 (rpL7 and rpS6,
respectively). A UV 260-nm trace revealed the individual ribosomal species (top panel). See also Figure S2C.
(C) Western blot (WB) of purified bulk ribosomes obtained from control, Lsm11-transfected, and Lsm10/Lsm11-transfected cells. The upper panel shows a
Coomassie-stained (CS) gel of purified ribosomes from the indicated transfected cells (lanes 1–4), and the lower panel shows immunoblots of the same fractions
to detect Lsm10, Lsm11, and ribosomal proteins L7 and S6 (rpL7 and rpS6, respectively) (lanes 1–4). Bulk ribosomes purified from the indicated transfected cells
were then subjected to anti-HA immunoprecipitation (IP) to enrich for those with Lsm10/Lsm11 bound. Shown is a Coomassie-stained gel of the respective IPs
(lanes 5–7). Note that Lsm10 and Lsm11 appear stoichiometric to ribosomal proteins in the Coomassie-stained gel (lane 7). Asterisk denotes an unidentifed band.
(D) Ribosomes from the indicated transfected cell extracts were purified by differential centrifugation (lanes 1–6), incubated for 30 min with increasing KOAc
concentrations at 37C, and re-sedimented. The pellet and the corresponding supernatants were analyzed by western blotting. Immunoblots against the
indicated proteins from ribosomal supernatants (lanes 7–13) and pellets (lanes 14–20) are shown. The same experiment was performed with the addition of 1%,
2%, and 4% NP-40 instead of salt. Immunoblots against the indicated proteins from ribosomal supernatant (lanes 21–23) and pellets (lanes 24–26) are shown.
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pICln Only Releases the Cognate Lsm10/Lsm11
Heterodimer from Ribosomes
The association of mature Lsm proteins with the ribosome may
represent the starting point in the snRNP assembly. If so, one
would predict that (1) the cognate Lsm10/Lsm11 heterodimer
is formed at the ribosomal exit tunnel and that (2) the assembly
chaperone pICln enables its ordered transfer onto the PRMT5
complex. As shown earlier, Lsm11 was able to establish the
interaction to ribosomes on its own, whereas Lsm10 required
the co-expression of Lsm11 for binding (Figure 1A [compare
panel b with panel d]; Figure 1B). To verify that the ribosomal
association of Lsm10 was dependent on Lsm11, a mutant of
Lsm11 (Lsm11DSm2) lacking the binding region for Lsm10 was
tested. While this mutant was still able to associate with ribo-
somes/polysomes, it failed to recruit Lsm10 upon co-transfec-
tion (Figure S2E). Next, we investigated whether pICln was
able to release a cognate Lsm10/Lsm11 heterodimer from its ri-
bosomal site of formation. For this, we co-expressed pICln either
with Lsm11 alone (Figure 3A, panel a), the cognate Lsm10/
Lsm11 dimer (Figure 3A, panel c), or the non-cognate proteins
Lsm11 and SmD1 (Figure 3A, panel d), and respective extracts
were size fractionated. Co-transfection of pICln caused efficient
ribosomal release of the Lsm10/Lsm11 heterodimer, as evident
by its redistribution from polysomes to lighter fractions of the
gradient (Figure 3A; compare panels b and c). pICln failed, how-
ever, to dissociate Lsm11 alone (Figure 3A, panel a) or co-ex-
pressed Lsm11 and SmD1 (Figure 3A, panel d). Furthermore,
when Lsm11DSm2, which is incapable of forming the Lsm10/
Lsm11 heterodimer, was co-expressed with Lsm10, pICln could
not promote its release from the ribosomes (Figure S3A).
In high-resolution density gradients, the Lsm10/Lsm11 hetero-
dimer, which was released by the co-transfection of pICln, was
found to co-sediment with pICln in the 6S–20S region of the
gradient (i.e., the size range of 6S and PRMT5 complexes; Fig-
ure S3B, lanes 2–12). Additionally, purified bulk ribosomes con-
tained markedly reduced levels of Lsm10/Lsm11 proteins upon
pICln co-transfection (Figure S3C; compare lanes 3 and 4), which
was confirmed by IP (Figure S3C; compare lanes 5 and 6). These
experiments illustrate the strict requirement for cognate Lsm
heterodimer formation for pICln-driven ribosome release.
Newly Translated Lsm10 and Lsm11 Proteins Interact
with pICln at the Ribosomes
Next, we asked whether pICln released newly synthesized Lsm
proteins from ribosomes rather than from a pre-existing cellular
pool thereof. We pulse-labeled either non-transfected cells
or cells co-expressing Lsm10/Lsm11, using [35S]-methionine.
Bulk ribosomes were then purified from these cells, and pICln
was added. Ribosomes were then pelleted, and Lsm10/Lsm11
was immunoprecipitated from the supernatant and analyzed by
western blotting (Figure 3B, lanes 1 and 2) and autoradiography
(Figure 3B, lanes 3 and 4). This revealed that pICln released
labeled and, therefore, newly synthesized Lsm10/Lsm11 hetero-
dimer from ribosomes. The formation and accumulation of
Lsm10/Lsm11 on ribosomes, hence, represents the earliest as-
yet documented intermediate in snRNP assembly.
Next, it was of interest to test whether pICln alone was suffi-
cient for ribosomal release of the cognate Lsm10/Lsm11 hetero-3106 Cell Reports 16, 3103–3112, September 20, 2016dimer. We purified ribosomes from cells co-transfected with
Lsm10 and Lsm11 and added increasing amounts of recom-
binant pICln (Figure 3C, upper panels). We found that pICln
(lanes 4–6, 8, and 14–15), but neither non-related control pro-
teins nor small molecules (lanes 7, 9–12, and 16) released ribo-
some-associated Lsm10/Lsm11 in a dose-dependent manner
and without the requirement of metabolic energy. Surprisingly,
the pICln-dependent release of the Lsm10/Lsm11 heterodimer
occurred quantitatively under physiological salt conditions,
despite the salt-resistant interaction of the Lsm10/Lsm11 heter-
odimer with ribosomes.
pICln Links the Translation of Lsm10/Lsm11 with RNP
Assembly
The dissociation of ribosome-bound Lsm10/Lsm11 by pICln
results in the formation of a pICln/Lsm10/Lsm11 complex.
This unit is analogous to the short-lived building block pICln/
SmD1/SmD2, which binds the PRMT5 complex and matures
into the 6S complex of spliceosomal snRNPs (Chari et al.,
2008; Neuenkirchen et al., 2015). Hence, we asked whether
pICln/Lsm10/Lsm11 released from the ribosome could be con-
verted into intermediates that resemble PRMT5 and 6S com-
plexes. Upon co-transfection, pICln, Lsm10 and Lsm11 were,
indeed, found to co-sediment in fractions corresponding to
these complexes (Figure 3D). Anti-FLAG IPs from these frac-
tions enabled us to characterize the U7 snRNP assembly inter-
mediates (Figure 3E, lanes 1–4). Immunoblotting (Figure 3E,
lanes 5 and 6) and mass spectrometry (Table S1) revealed
that the 20S peak contained the PRMT5 complex bound to
Lsm10/Lsm11 and all spliceosomal Sm proteins. In contrast,
the U7-specific 6S complex consists of pICln, SmE/SmF/
SmG, and Lsm10/Lsm11 (Pillai et al., 2001, 2003). Thus,
pICln-mediated ribosomal release of the Lsm10/Lsm11 hetero-
dimer primes these proteins for U7 snRNP assembly by the
formation of distinct intermediates.
Finally, we wanted to investigate whether the formation of spli-
ceosomal snRNPs likewise entails an early ribosome-associated
phase as described earlier for the U7 particle. Hence, we inves-
tigated the fate of the Lsm10/Lsm11 paralogs, SmD1/SmD2,
upon reduction of pICln levels by RNAi (Figure 4A, left panel).
A strong association of SmD1/SmD2 with ribosomes and poly-
somes became apparent upon pICln reduction in comparison
to the mock-transfected control (Figure 4A, panels a and b).
Conversely, the restoration of pICln levels by transfection of
exogenous HA-pICln selectively reduces ribosomal SmD1/
SmD2 both in control and pICln-siRNA (small interfering RNA)-
transfected cells (Figure 4A, panels c and d). Additionally,
exogenous pICln was able to release the SmD1/SmD2 hetero-
dimer from the purified ribosomes (Figure S3D). Thus, not only
Lsm10/Lsm11 but also SmD1/SmD2 proteins remain bound to
the ribosome as full-length proteins and are only released in a
pICln-mediated reaction when the respective cognate Sm/Lsm
heterooligomers have formed.
DISCUSSION
In this study, we have elucidated how newly synthesized Sm/
Lsm proteins are incorporated into the assisted assembly
Figure 2. Retention of Full-Length Lsm Proteins in Proximity of the Ribosomal Exit Tunnel
(A) Western blot analysis of cytoplasmic extracts fractionated by density gradient uponmock (control) or micrococcal nuclease (MNase) treatment (upper panel).
The same experiment as in the upper panel, however, using purified ribosomes/polysomes is shown in the lower panel. Note the absence of Lsm10/Lsm11
(legend continued on next page)
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pathway of snRNPs. Our data suggest that full-length SmD2 and
Lsm11 proteins initially remain bound to the ribosome at a site
in proximity to the polypeptide exit tunnel (Figure 4). While the
sequestration of nascent polypeptides on the ribosome elicited
by stalling has been described previously (Albane`se et al.,
2006; Gong and Yanofsky, 2002; Keenan et al., 2001; Mariappan
et al., 2010; Schuldiner et al., 2008), to our best knowledge, the
interaction of Sm/Lsm proteins documented here represents the
first observation of full-length proteins being retained in prox-
imity to the polypeptide exit tunnel. The interaction with the ribo-
some is mediated by Lsm11 and, by analogy, SmD2. However,
both proteins cannot directly interact with the assembly chap-
erone pICln (Chari et al., 2008; Grimm et al., 2013). Thus, to
proceed in the pathway, two prerequisites must be met: (1) for-
mation of a cognate Lsm10/Lsm11 or SmD1/SmD2 heterodimer
(Figure 4B, Ia and IIa) and (2) the interaction with pICln mediated
by Lsm10 and SmD1, respectively (Figure 4B, Ib and IIb). This
prevents an un-chaperoned release into the cytosol and leads
to the ordered formation of pICln/SmD1/SmD2 and pICln/
Lsm10/Lsm11 (Figure 4B, Ic and IIc). Of note, both complexes
pre-determine the subsequent assembly pathway: whereas the
pICln/Lsm10/Lsm11 complex is converted at the PRMT5 com-
plex into a 6S complex predestined for U7 snRNPs (i.e., pICln/
Lsm10/Lsm11/SmF/SmE/SmG; Figure 4B, Id), pICln/SmD1/
SmD2 forms the 6S complex specific for spliceosomal snRNPs
(i.e., pICln/SmD1/SmD2/SmF/SmE/SmG; Figure 4B, IId). Thus,
the orchestration of consecutive specific protein-protein inter-
actions on the ribosome drives early events in the assembly
pathway.
Recent studies depict the ribosome as a central hub, where
productive protein folding is integrated with both protein and
mRNA quality control (Harigaya and Parker, 2010; Pechmann
et al., 2013; Rodrigo-Brenni and Hegde, 2012). Subunits of
macromolecular assemblies often display hydrophobic interac-
tion surfaces with a high tendency for aggregation with non-
cognate cellular components (Chari and Fischer, 2010; Ellis,
2013). Therefore, it appears appropriate that specialized assem-
bly pathways for newly synthesized subunits should be initiated
at the ribosome itself. Although the results presented here are
highly specific for snRNPs, the same principles are likely to apply
to the assembly of othermacromolecular complexes aswell. Our
findings indicate that the coordinated hand-off of newly trans-
lated proteins from the ribosome to dedicated assembly chaper-
ones might be a widespread phenomenon in ensuring faithful
macromolecular complex assembly in living cells. The recentapparently sedimenting in sub-ribosomal fractions when purified ribosomes/poly
gradients revealed the migration of ribosomal species in each gradient.
(B) Western blot analysis of cytoplasmic extracts fractionated by density gradient
were treated with either MNase (a) or MNase and EDTA (b) to study the sedimen
ribosomal subunits and polysomes are shown. UV traces on top of the gradien
Figures S2A and S2B.
(C) 80S-antibody-80S trimeric complexes were purified from 293T cytoplasmic ex
on the EMgrid was intentionally kept low tomake sure that the 80S ribosomeswer
next to each other (upper lane of a). The orientation of 80S ribosomes within the
human 80S ribosomes (lower lane of a). Single raw image and schematic of ribos
antibody at the interface between two 80S ribosomes cannot be exactly determin
respective binding site of the antibody in position for ribosome-bound HA-Lsm1
representation of the Lsm11 binding site on the ribosome is shown (d).
3108 Cell Reports 16, 3103–3112, September 20, 2016finding of co-translational assembly of operon-encoded lucif-
erase subunits LuxA and LuxB in E. coli suggests that similar
mechanisms described here for eukaryotes may likewise ac-
count for macromolecular complex formation in prokaryotes
(Shieh et al., 2015).
EXPERIMENTAL PROCEDURES
Cell Culture and Cytoplasmic Extract Preparation
293T cells were grown, maintained at 37C, and transfected with Nanofectin
at 70%–80% confluency (PAA Laboratories). Transfection of siRNA was
performed with Lipofectamine RNAiMAX (Invitrogen).
To prepare cytoplasmic extracts, cells were washed and re-suspended in
lysis buffer (50 mM HEPES-KOH (pH 7.5), 120 mM KOAc, 5 mM Mg(OAc)2,
5 mM DTT, 100 U/ml RNasin, and protease inhibitors) containing 0.5% (v/v)
NP-40. In cases where polysomes were analyzed, cells were incubated with
100 mg/ml cycloheximide at 37C for 15 min, and the lysis buffer additionally
contained 100 mg/ml cycloheximide. The cells were incubated for 20 min on
ice and inverted every 5 min. Lysates were cleared by centrifugation at
13,000 rpm for 15 min at 4C in a table-top centrifuge. Extracts were always
prepared fresh prior to each experiment.
Purification of Ribosomes
For ribosome purification, 293T cytoplasmic extract was filtered through a
0.45-mm syringe filter (Pall) and then layered on a 45% (w/v) sucrose cushion
in cushion/gradient buffer (50 mM HEPES-KOH (pH 7.5), 120 mM KOAc,
5 mM Mg(OAc)2, 5 mM DTT, and 10 mg/ml cycloheximide). The cushion was
subjected to centrifugation at 70,000 rpm at 4C for 2 hr in a TLA 100.3 rotor
(Beckman Coulter). Afterward, the supernatant was decanted and transferred
to a fresh tube. The pellet was washed with PBS or re-suspension buffer
(50 mM HEPES-KOH [pH 7.5], 120 mM KOAc, 5 mM Mg(OAc)2, and 5 mM
DTT). The pellet was gently re-suspended in PBS in the case where the re-sus-
pended pellet was directly subjected to SDS-PAGE or in re-suspension buffer
in the case where the re-suspended pellet was used for further functional ex-
periments. Re-suspension was achieved by adding buffer to the pellet and
gentle shaking on a rotary shaker for 2 hr at 4C so that no frothing occurred.
Density Gradient Centrifugation
All gradients were prepared with a Biocomp Gradient Master (Science Ser-
vices). To resolve 6S and PRMT5 complexes, 293T extract was layered on
top of linear 10%–30% (w/v) galactose gradient in PBS buffer. Gradients
were subjected to centrifugation at 40,000 rpm for 16 hr at 4C in SW60Ti rotor
(Beckman Coulter) and harvested manually. To obtain 40S, 60S, 80S, and pol-
ysomal fractions, 293T extract was layered on top of a 5%–45% (w/v) sucrose
gradient in gradient/cushion buffer. Gradients were subjected to centrifugation
at 34,500 rpm for 2 hr at 4C in a SW 41Ti rotor (Beckman Coulter). Gradients
were harvested on aBiocompPiston Gradient Fractionator (Science Services).
To resolve 40S, 60S, and 80S ribosomes, extracts were layered on 5%–45%
(w/v) sucrose gradients in gradient/cushion buffer and sedimented at
17,000 rpm for 16 hr at 4C in a SW 60Ti rotor (Beckman Coulter)
and harvested manually. For high-resolution gradients, 293T extract wassomes are utilized (compare upper and lower panels). UV traces on top of the
centrifugation. Extracts obtained from cells co-transfected with Lsm10/Lsm11
tation pattern of Lsm10/Lsm11. Note that only the fractions corresponding to
ts revealed the migration of ribosomal species in the each gradient. See also
tracts according to Experimental Procedures. The concentration of complexes
e juxtapositioned by the anti-FLAG antibodies and not coincidentally positioned
80S-antibody-80S complex was evaluated based on the known structure of
omes juxtaposed by the anti-FLAG antibody (b). The exact binding site of the
ed in a single image. Rectangles were thus modeled to the 80S structure at the
1-FLAG, which is in proximity to the polypeptide exit tunnel (c). A schematic
Figure 3. U7 snRNP Assembly Is Initiated Already at the Ribosome
(A) Cells were co-transfected with plasmids encoding either for Lsm11 and pICln (a), Lsm10/Lsm11 (b), Lsm10/Lsm11 and pICln (c), or SmD1/Lsm11 and pICln
(d). Extracts derived from these cells were separated by gradient centrifugation and analyzed by western blotting with anti-HA antibody to detect Lsm and Sm
proteins. To detect pICln, anti-pICln antibodies were used. A representative ribosomal profile is shown in the top panel. Asterisk denotes an unidentified band.
See also Figures S3B and S3C.
(B) Either non-transfected cells or cells co-transfected with Lsm10 and Lsm11 were pulse-labeled with [35S]-methionine, bulk ribosomes were purified by dif-
ferential centrifugation, and purified recombinant pICln was added. After incubation, ribosomes were re-sedimented, and the supernatants were additionally
immunoprecipitated with anti-HA beads and resolved by SDS-PAGE. Shown are immunoblots and the corresponding autoradiography of the anti-HA immu-
noprecipitates from non-transfected cells (lanes 1 and 3, respectively) or cells simultaneously co-transfected with Lsm10 and Lsm11 (lanes 2 and 4, respectively).
Asterisk denotes an unidentified band.
(C) Lsm10/Lsm11-containing ribosomes were incubated with increasing concentrations of pICln and subjected to differential centrifugation. Western blots of the
individual ribosomal pellets (lanes 1–3) and corresponding supernatants (lanes 4–6) using antibodies against HA tag or ribosomal protein L7 (rpL7) are shown. The
same ribosomal release reaction as in lanes 1–6 was performed with mock, pICln, BSA, heparin, GroEL, spermidine (lanes 7–13), and TRiC/CCT (lane 16)
treatment. See also Figure S3E.
(legend continued on next page)
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Figure 4. pICln Releases the Canonical
SmD1/D2 Heterodimer from the Ribosome
(A) Extracts prepared from non-transfected control
cells and cells transfectedwith a siRNA pool directed
against pICln mRNA were used. Left panel shows
western blot analysis using antibodies against pICln
and tubulin as a loading control. Right panels show
the sedimentation analysis of endogenous SmD1/
SmD2 in extracts of control cells (a), pICln-depleted
cells (b), pICln-overexpressing control cells (c), and
cells in which the depleted endogenous pICln pool
was replenished upon exogenous pICln expression
(d). See also Figure S3D.
(B) A schematic model of the earliest cellular snRNP
assembly stages. Newly translated Lsm11 and
SmD2 proteins are not released from the ribosome
but require the formation of a cognate Sm/Lsm
protein heterodimer (steps Ia and IIa, respectively).
The assembly chaperone pICln then binds and
dissociates the cognate heterodimer (steps Ib and
IIb), leading to the formation of pICln/Lsm10/Lsm11
(step Ic) or pICln/SmD1/SmD2 (step IIc). Both units
are then bound to the PRMT5 complex, where they
are converted to either the U7-specific (step Id) or
spliceosomal (step IId) 6S complexes upon the
addition of SmE/SmF/SmG. The U7 snRNP (step Ie)
or spliceosomal snRNPs (step IIe) are formed by
the dissociation of pICln and the addition of the
respective snRNA at the SMN complex (data not
shown; see also Discussion).layered on top of a 5%–40% (w/v) sucrose gradient in gradient/cushion buffer
and sedimented at 40,000 rpm for 4 hr at 4C in a SW 40Ti rotor (Beckman
Coulter).
MNase, Puromycin Treatment of Extracts, and Translation Runoff
Experiment
Cytoplasmic extracts and/or purified ribosomes/polysomes were supple-
mented with CaCl2 to a final concentration of 2 mM. 150 U MNase was(D) Plasmids encoding Lsm10, Lsm11, and pICln were co-transfected into cells and subsequently analyze
described in Figure 1A. The fractions corresponding to 6S and PRMT5 complexes are indicated.
(E) Coomassie-stained gel (lanes 1 and 2) and western blot analysis (lanes 5 and 6) of co-purified proteins a
complex fractions shown in (D). The inset (lanes 3 and 4) shows a silver-stained portion of the same gel for b
See also Table S1.
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polysomes were incubated at 20C for 30 min.
For the combined treatment of extracts with
both MNase and EDTA, the latter was added to a
final concentration of 50 mM. Treated samples
were then layered on 5%–45% (w/v) sucrose gra-
dients and centrifuged at 17,000 rpm for 16 hr
at 4C in a SW 60Ti rotor, as in Figure 2B, or at
34,500 rpm for 2 hr at 4C in a SW 40Ti rotor, in
Figure 2A. Individual fractions were analyzed by
SDS-PAGE and western blotting.
To study the effect of puromycin, cells were incu-
bated with 5 mM puromycin for 30 min prior to
preparation of the extract, and lysis buffer con-
tained 5 mM puromycin. Extract was layered on a
40% sucrose cushion containing 1 mM puromycin,
and ribosomes were pelleted as described earlier.
Ribosomal pellets were re-suspended in re-sus-pension buffer containing 1 mM puromycin. Re-suspended ribosomes were
further incubated at room temperature in the presence of 5 mM puromycin
and 250 mM salt for 30 min before fractionation on a 5%–45% sucrose
gradient.
To run off translation, cells co-transfected with Lsm10 and Lsm11 were
incubated with 100 mg/ml cycloheximide for 2 hr at 37C. Extract was prepared
and incubated at 37C for 2 hr in the presence of 5 mM ATP and 100 U/ml
RNasin.d by gradient centrifugation and western blotting, as
ssociated with HA-Lsm11-FLAG in 6S- and PRMT5-
etter appreciation of low-molecular-weight proteins.
Ribosome Release Reactions with pICln
Cytoplasmic extracts were prepared from 293T cells transfected with the
indicated plasmids. Extracts were subjected to differential centrifugation,
and ribosomal pellets were carefully re-suspended as described earlier.
The UV absorption at 260 nm was measured, and the concentration of ri-
bosomes was determined by using the conversion factor, which assumes
that one OD260 (optical density at 260 nm) unit corresponds to 20 pmol
of ribosomes. For ribosome release reactions, increasing amounts of re-
combinant pICln (Chari et al., 2008) (0-, 5-, and 50-fold molar excess
over ribosomes), control proteins, or small molecules (at 50-fold molar
excess over ribosomes) were added to a constant amount (150–200
pmol) of re-suspended ribosomes. The reaction was incubated for
30 min at 37C. Immediately after the completion of incubation, the reac-
tion tubes were transferred to ice, and an equal volume of re-suspension
buffer was added. The reaction was then subjected to differential centrifu-
gation as described earlier, and supernatants and re-suspended pellets
were analyzed by western blotting.
Pulse Labeling
Cells co-transfected with plasmids encoding Lsm10 and Lsm11 or non-trans-
fected cells were used. 24 hr after transfection, the mediumwas removed, and
cells were washed with medium without methionine. Afterward, cells were
incubated with medium without methionine for 1 hr (starvation). Thereafter,
the medium was removed, and cells were incubated with medium containing
[35S]-methionine at a concentration of 20 mCi/ml for 1 hr. Extracts were
prepared as described earlier.
Immuno-EM
For immuno- EM sample preparation, cytoplasmic extracts prepared from
293T cells co-transfected with HA-Lsm10 and HA-Lsm11-FLAG were
subjected to MNase treatment as described earlier. Subsequently, ribo-
somes were isolated by differential centrifugation as described earlier. For
labeling with antibodies, ribosomes containing HA-Lsm10 and HA-Lsm11-
FLAG were re-suspended and incubated with different concentrations of
anti-FLAG antibody. The antibody concentration, which yielded the highest
proportion of 80S-antibody-80S trimers was then empirically determined
by negative-stain EM. These trimers were then enriched by 5%–45% (w/v)
sucrose gradients run at 17,000 rpm for 16 hr in a SW 60Ti rotor (Beckman
Coulter) at 4C. The appropriate fraction was then re-analyzed by negative-
stain EM, as described previously (Chari et al., 2008). Images were recorded
on a Philips CM200 electron microscope (Philips/FEI) operated at 160 kV us-
ing a 2-fold-binned 4kx4k CCD (charge-coupled device) camera (TemCam-
F415, TVIPS) at a magnification of 119,000-fold, resulting in a pixel size of
2.5 A˚. The concentration of particles on the EM grid was chosen to be
very low to ensure that 80S dimers were not formed accidentally by high
concentrations of ribosomes. Fifty 80S-antibody-80S trimers were selected
to determine the Lsm11 binding site on the ribosome. The projection direc-
tion of each 80S ribosome was determined, and a rectangular plane was
drawn in 3D, perpendicular to the imaging plane at the antibody-binding
site (Figure 2C). The x and y dimensions of the rectangular planes reflect
the uncertainties of detecting the binding site of the antibody. The overlap-
ping area of all rectangular planes, therefore, describes the position of the
anti-FLAG antibody. We were thus able to determine the location of the
Lsm11 binding site on the ribosome and find it to lie in proximity to the poly-
peptide exit tunnel as shown in Figure 2C.
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